Drug class: Cannabinoid
Other names: Weed, Pot, Hash, Mary Jane
Onset of action: 5-10 minutes (inhaled), 30 minutes – 2 hours (ingested)
Peak: 15-30 minutes (inhaled), 2-5 hours (ingested)
Did you know?
- Marijuana has been used for entheogenic experiences in various cultures throughout Asia, India, Europe, North America, and South America. Earliest use is estimated ~2,700 BC.
- Cannabis has many routes of administration: smoking, vaping, ingesting orally, and applying to skin topically.
- In 2021, MAPS was awarded a $12.9M grant from Michigan to expand cannabis research for Veterans with PTSD.
See what’s happening in today’s marijuana news.
Intelligence Squared: Legalize Psychedelics with Rick Doblin, Ph.D. and Bia Labate, Ph.D.
April 22, 2021
Summary: MAPS Founder and Executive Director Rick Doblin, Ph.D., and Bia Labate, Ph.D., MAPS Public Education and Culture Specialist and Chacruna Institute Executive Director, provided compelling arguments …
Mind Medicine Australia Podcast: Rick Doblin, Ph.D.: MDMA – History, Toxicity, and Therapeutic Use
March 21, 2021
Summary: Rick Doblin, Ph.D., MAPS Founder and Executive Director, explains the history, stigma, pharmacology, and therapeutic potential of MDMA on the Mind Medicine Australia Podcast. “Based on this …
TED Radio Hour on NPR: Rick Doblin: How Can We Use Psychedelic-Assisted Therapy To Treat Trauma?
March 20, 2021
Summary: TED Radio Hour on NPR welcomes MAPS Founder Rick Doblin, Ph.D., for a discussion with Manoush Zomorodi about clinical research into treating mental health conditions with psychedelic-assisted …
CBC Radio: Why Some Investors and Medical Researchers Are Looking Past Pot to Psychedelic Drugs (Podcast)
September 9, 2018
Summary: CBC Radio highlights the therapeutic use of psychedelics in a new series, exploring how the shifting public perception and rise of acceptance is influencing an increase in financial support for …
Sounds True: Rick Doblin: The Psychedelic Renaissance (Podcast)
July 31, 2018
Summary: MAPS Founder Rick Doblin, Ph.D., speaks to Sounds True about the progress of MDMA-assisted psychotherapy for PTSD in clinical research contexts, and shares personal experiences that led to his …
Investing in Cannabis: The Psychedelic Studies of MAPS (Podcast)
June 11, 2018
Summary: Investing in Cannabis features an episode with MAPS Founder Rick Doblin, Ph.D., where they discuss marijuana and psychedelic research, the PTSD epidemic, and drug policy reform. Originally appearing …
Fox News: Gutfeld On Using Ecstasy To Cure PTSD (Video)
May 3, 2018
Summary: The Five on Fox News examines the history of MAPS, the current PTSD epidemic in veterans, and how MDMA combined with psychotherapy is showing promising results in treating PTSD. “I think …
Applied Curiosity Lab: Ep. 019: Turning Psychedelics Into Medicine with Rick Doblin (Podcast)
January 18, 2018
Summary: Applied Curiosity Lab interviews MAPS Founder Rick Doblin, Ph.D., about his enduring goal of turning psychedelics and marijuana into prescription medicines. Originally appearing here. What are …
NBC Nightly News: Marijuana May Hold Promise for Veterans with PTSD (Video)
December 1, 2017
Summary: NBC Nightly News covers MAPS’ clinical trial researching the efficacy of smoked marijuana for treating veterans’ symptoms of PTSD. Veteran Roberto Pickering is interviewed about the …
The Third Wave: Why New Drug Policy Needs To Be About Justice (Video)
August 24, 2017
Summary: The Third Wave interviews Natalie Lyla Ginsberg of MAPS about drug policy reform, reducing the stigma surrounding psychedelics, and her role as policy and advocacy director at MAPS. Originally …
Voices in the Dark: Psychedelic Therapy Goes Mainstream: Rick Doblin Interview (Video)
July 7, 2017
Summary: Voices in the Dark interviews MAPS Founder Rick Doblin, Ph.D., at Breaking Convention 2017 about the history and politics surrounding psychedelic research, MDMA-assisted psychotherapy as a treatment …
More Than Zero: Reclassifying Marijuana Could Have A Significant Impact On Drug Policy
February 7, 2014
Forbes investigates the laws and politics surrounding marijuana, noting how medical marijuana research is being blocked by federal agencies. The article highlights President Obama’s recent comments about …